Perceptions of young women using SSRI antidepressants - A reclassification of stigma

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Perceptions of young women using SSRI antidepressants - A reclassification of stigma. / Knudsen, Pia; Hansen, Ebba Holme; Traulsen, Janine M.

In: International Journal of Pharmacy Practice, Vol. 10, No. 4, 01.12.2002, p. 243-252.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Knudsen, P, Hansen, EH & Traulsen, JM 2002, 'Perceptions of young women using SSRI antidepressants - A reclassification of stigma', International Journal of Pharmacy Practice, vol. 10, no. 4, pp. 243-252. https://doi.org/10.1211/096176702776868415

APA

Knudsen, P., Hansen, E. H., & Traulsen, J. M. (2002). Perceptions of young women using SSRI antidepressants - A reclassification of stigma. International Journal of Pharmacy Practice, 10(4), 243-252. https://doi.org/10.1211/096176702776868415

Vancouver

Knudsen P, Hansen EH, Traulsen JM. Perceptions of young women using SSRI antidepressants - A reclassification of stigma. International Journal of Pharmacy Practice. 2002 Dec 1;10(4):243-252. https://doi.org/10.1211/096176702776868415

Author

Knudsen, Pia ; Hansen, Ebba Holme ; Traulsen, Janine M. / Perceptions of young women using SSRI antidepressants - A reclassification of stigma. In: International Journal of Pharmacy Practice. 2002 ; Vol. 10, No. 4. pp. 243-252.

Bibtex

@article{f700676234804b36b05a14de22a37190,
title = "Perceptions of young women using SSRI antidepressants - A reclassification of stigma",
abstract = "Objective - To contribute to an understanding of young women's perspective on using selective serotonin re-uptake inhibitors (SSRIs). Method - Eight in-depth interviews and four re-interviews were conducted with young women (aged 21-34) using SSRIs. Informants were recruited through pharmacies in Copenhagen, Denmark. Pharmacy personnel identified potential participants based on dispensed prescriptions and gave them a contact letter with information about the study. Key findings - When suffering from emotional problems, the women saw themselves as dysfunctional in their daily lives. They felt that they deviated from what is considered {"}normal{"} in society and thus felt stigmatised. When the women contacted their physicians they were prescribed SSRIs. After starting the medication, the women felt that they could once again function in everyday life and they felt relieved. However, the women also associated taking SSRIs with stigmatisation due to the reputation of the medicines as {"}happiness pills{"} and the association with mental instability. The women concealed their emotional problems and medication from most people in their social networks. This was the result of the women's own anticipation of being stigmatised and their fear of negative reactions from others if they revealed the truth. Conclusion - The young women using SSRIs felt stigmatised, initially due to their emotional problems. After the women were diagnosed, the stigma was reclassified and then became associated with taking SSRIs. The women coped primarily by trying to pass for normal. Our findings show that the SSRI users attach psychological and social meanings to their use of the drugs. Pharmacy professionals need to be aware of such meanings if they are to enhance their role in patient care.",
author = "Pia Knudsen and Hansen, {Ebba Holme} and Traulsen, {Janine M.}",
year = "2002",
month = dec,
day = "1",
doi = "10.1211/096176702776868415",
language = "English",
volume = "10",
pages = "243--252",
journal = "International Journal of Pharmacy Practice",
issn = "0961-7671",
publisher = "JohnWiley & Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Perceptions of young women using SSRI antidepressants - A reclassification of stigma

AU - Knudsen, Pia

AU - Hansen, Ebba Holme

AU - Traulsen, Janine M.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Objective - To contribute to an understanding of young women's perspective on using selective serotonin re-uptake inhibitors (SSRIs). Method - Eight in-depth interviews and four re-interviews were conducted with young women (aged 21-34) using SSRIs. Informants were recruited through pharmacies in Copenhagen, Denmark. Pharmacy personnel identified potential participants based on dispensed prescriptions and gave them a contact letter with information about the study. Key findings - When suffering from emotional problems, the women saw themselves as dysfunctional in their daily lives. They felt that they deviated from what is considered "normal" in society and thus felt stigmatised. When the women contacted their physicians they were prescribed SSRIs. After starting the medication, the women felt that they could once again function in everyday life and they felt relieved. However, the women also associated taking SSRIs with stigmatisation due to the reputation of the medicines as "happiness pills" and the association with mental instability. The women concealed their emotional problems and medication from most people in their social networks. This was the result of the women's own anticipation of being stigmatised and their fear of negative reactions from others if they revealed the truth. Conclusion - The young women using SSRIs felt stigmatised, initially due to their emotional problems. After the women were diagnosed, the stigma was reclassified and then became associated with taking SSRIs. The women coped primarily by trying to pass for normal. Our findings show that the SSRI users attach psychological and social meanings to their use of the drugs. Pharmacy professionals need to be aware of such meanings if they are to enhance their role in patient care.

AB - Objective - To contribute to an understanding of young women's perspective on using selective serotonin re-uptake inhibitors (SSRIs). Method - Eight in-depth interviews and four re-interviews were conducted with young women (aged 21-34) using SSRIs. Informants were recruited through pharmacies in Copenhagen, Denmark. Pharmacy personnel identified potential participants based on dispensed prescriptions and gave them a contact letter with information about the study. Key findings - When suffering from emotional problems, the women saw themselves as dysfunctional in their daily lives. They felt that they deviated from what is considered "normal" in society and thus felt stigmatised. When the women contacted their physicians they were prescribed SSRIs. After starting the medication, the women felt that they could once again function in everyday life and they felt relieved. However, the women also associated taking SSRIs with stigmatisation due to the reputation of the medicines as "happiness pills" and the association with mental instability. The women concealed their emotional problems and medication from most people in their social networks. This was the result of the women's own anticipation of being stigmatised and their fear of negative reactions from others if they revealed the truth. Conclusion - The young women using SSRIs felt stigmatised, initially due to their emotional problems. After the women were diagnosed, the stigma was reclassified and then became associated with taking SSRIs. The women coped primarily by trying to pass for normal. Our findings show that the SSRI users attach psychological and social meanings to their use of the drugs. Pharmacy professionals need to be aware of such meanings if they are to enhance their role in patient care.

UR - http://www.scopus.com/inward/record.url?scp=0036967896&partnerID=8YFLogxK

U2 - 10.1211/096176702776868415

DO - 10.1211/096176702776868415

M3 - Journal article

AN - SCOPUS:0036967896

VL - 10

SP - 243

EP - 252

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 4

ER -

ID: 228774726